Financial Statements · Financial Reporting

Takeda Pharma OÜ

Official identifier 10323690Record date 31 Mar 2023
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2022
Period start
1 Apr 2022
Submitted date
22 Sep 2023

Report

Consolidated
No
Audited
Yes

Financial metrics

StatementMetricValue
Balance sheetAssets2,613,000
Balance sheetCash and cash equivalents114,000
Balance sheetCurrent assets2,316,000
Balance sheetCurrent liabilities502,000
Balance sheetEquity1,965,000
Balance sheetShare capital at nominal value141,000
Balance sheetNon-current assets297,000
Balance sheetNon-current liabilities146,000
Balance sheetRetained earnings (loss) from previous periods389,000
Kahjumi katmise ettepanekRetained earnings (loss) from previous periods389,000
Income statement scheme 1Depreciation and impairment of non-current assets0
Income statement scheme 1Labour costs0
Income statement scheme 1Revenue1,870,000
Income statement scheme 1Annual period profit / loss85,000
Income statement scheme 1Operating profit (loss)72,000
Income statement scheme 1Profit (loss) before income tax85,000
Note: Labour costsEmployees10
Note: Labour costsLabour costs-853,000

Linked company

Company: Takeda Pharma OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements